Zhu E, Zhong M, Liang T, Liu Y, Wu K, Zhang Z
J Inflamm Res. 2024; 17:693-710.
PMID: 38332898
PMC: 10849919.
DOI: 10.2147/JIR.S440374.
Kim Y, Kim W, Kim J, Moon J, Park S, Park C
Electrolyte Blood Press. 2023; 20(2):39-48.
PMID: 36688208
PMC: 9827046.
DOI: 10.5049/EBP.2022.20.2.39.
Gunduz N, Buz A, Kabaalioglu A
Medeni Med J. 2021; 36(3):209-216.
PMID: 34915678
PMC: 8565583.
DOI: 10.5222/MMJ.2021.65021.
Zhang B, Zhang X, Zhang C, Sun G, Sun X
Pharm Res. 2021; 38(11):1807-1820.
PMID: 34773184
DOI: 10.1007/s11095-021-03104-x.
Hsiao C, Hou Y, Liu Y, Ko J, Lee C
Antioxidants (Basel). 2021; 10(5).
PMID: 34066452
PMC: 8148201.
DOI: 10.3390/antiox10050733.
Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney Disease.
Wang Y, He W
Front Pharmacol. 2021; 12:630617.
PMID: 33859563
PMC: 8042272.
DOI: 10.3389/fphar.2021.630617.
Chronic kidney disease in patients with diabetes mellitus.
Nordheim E, Jenssen T
Endocr Connect. 2021; 10(5):R151-R159.
PMID: 33830068
PMC: 8111312.
DOI: 10.1530/EC-21-0097.
Diagnostic roles of urinary kidney microvesicles in diabetic nephropathy.
Cai F, Wu W, Zhou X, Yu X, Lv J, Wang S
Ann Transl Med. 2020; 8(21):1431.
PMID: 33313176
PMC: 7723537.
DOI: 10.21037/atm-20-441.
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations.
Leoncini G, Viazzi F, De Cosmo S, Russo G, Fioretto P, Pontremoli R
J Nephrol. 2020; 33(5):949-963.
PMID: 32681470
PMC: 7557495.
DOI: 10.1007/s40620-020-00803-3.
Low-Energy Extracorporeal Shock Wave Therapy Ameliorates Kidney Function in Diabetic Nephropathy.
Hsiao C, Huang W, Cheng K, Lee C
Oxid Med Cell Longev. 2019; 2019:8259645.
PMID: 31354913
PMC: 6637677.
DOI: 10.1155/2019/8259645.
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach.
Bonino B, Leoncini G, De Cosmo S, Greco E, Russo G, Giandalia A
Medicina (Kaunas). 2019; 55(7).
PMID: 31315312
PMC: 6681235.
DOI: 10.3390/medicina55070382.
Ferulic Acid Protects Hyperglycemia-Induced Kidney Damage by Regulating Oxidative Insult, Inflammation and Autophagy.
Chowdhury S, Ghosh S, Das A, Sil P
Front Pharmacol. 2019; 10:27.
PMID: 30804780
PMC: 6371841.
DOI: 10.3389/fphar.2019.00027.
Lysyl oxidases expression and histopathological changes of the diabetic rat nephron.
Chen J, Ren J, Loo W, Hao L, Wang M
Mol Med Rep. 2017; 17(2):2431-2441.
PMID: 29207131
PMC: 5783488.
DOI: 10.3892/mmr.2017.8182.
C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation.
Lee J, Koh A, Jeong H, Kim E, Ha T, Saleem M
Sci Rep. 2017; 7(1):12346.
PMID: 28955049
PMC: 5617844.
DOI: 10.1038/s41598-017-12382-8.
Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L
Kidney Int. 2017; 93(1):95-109.
PMID: 28750927
PMC: 5818994.
DOI: 10.1016/j.kint.2017.05.013.
Classification and Differential Diagnosis of Diabetic Nephropathy.
Qi C, Mao X, Zhang Z, Wu H
J Diabetes Res. 2017; 2017:8637138.
PMID: 28316995
PMC: 5337846.
DOI: 10.1155/2017/8637138.
World diabetes day 2013: diabetes mellitus and nephrology.
Hajivandi A, Amiri M
J Nephropharmacol. 2017; 2(2):31-32.
PMID: 28197442
PMC: 5297550.
Dietary zinc modifies diabetic-induced renal pathology in rats.
Elsaed W, Mohamed H
Ren Fail. 2016; 39(1):246-257.
PMID: 27882813
PMC: 6014501.
DOI: 10.1080/0886022X.2016.1256321.
Renal Biopsy in Type 2 Diabetic Patients.
Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Seron D
J Clin Med. 2015; 4(5):998-1009.
PMID: 26239461
PMC: 4470212.
DOI: 10.3390/jcm4050998.
On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view.
Nasri H
J Renal Inj Prev. 2014; 2(2):31-2.
PMID: 25340120
PMC: 4206002.
DOI: 10.12861/jrip.2013.11.
